SLYND Drug Patent Profile
✉ Email this page to a colleague
When do Slynd patents expire, and when can generic versions of Slynd launch?
Slynd is a drug marketed by Exeltis Usa Inc and is included in one NDA. There are fifteen patents protecting this drug and one Paragraph IV challenge.
This drug has sixty-nine patent family members in thirty-one countries.
The generic ingredient in SLYND is drospirenone. There are eleven drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the drospirenone profile page.
DrugPatentWatch® Generic Entry Outlook for Slynd
There have been two patent litigation cases involving the patents protecting this drug, indicating strong interest in generic launch. Recent data indicate that 63% of patent challenges are decided in favor of the generic patent challenger and that 54% of successful patent challengers promptly launch generic drugs.
There is one tentative approval for the generic drug (drospirenone), which indicates the potential for near-term generic launch.
Indicators of Generic Entry
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for SLYND?
- What are the global sales for SLYND?
- What is Average Wholesale Price for SLYND?
Summary for SLYND
International Patents: | 69 |
US Patents: | 15 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 79 |
Patent Applications: | 2,185 |
Drug Prices: | Drug price information for SLYND |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for SLYND |
What excipients (inactive ingredients) are in SLYND? | SLYND excipients list |
DailyMed Link: | SLYND at DailyMed |


Paragraph IV (Patent) Challenges for SLYND
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
SLYND | Tablets | drospirenone | 4 mg | 211367 | 1 | 2022-01-07 |
US Patents and Regulatory Information for SLYND
SLYND is protected by fifteen US patents.
International Patents for SLYND
When does loss-of-exclusivity occur for SLYND?
Based on analysis by DrugPatentWatch, the following patents block generic entry in the countries listed below:
Argentina
Patent: 1670
Patent: COMPOSICION FARMACEUTICA QUE COMPRENDE DROSPIRENONA Y KIT ANTICONCEPTIVO
Estimated Expiration: ⤷ Try for Free
Australia
Patent: 11273605
Patent: Pharmaceutical composition comprising drospirenone and contraceptive kit
Estimated Expiration: ⤷ Try for Free
Brazil
Patent: 2012033391
Patent: kit contraceptivo, método contraceptivo para uma paciente do sexo feminino necessitando do mesmo e composição farmacêutica compreendendo drospirenova.
Estimated Expiration: ⤷ Try for Free
Patent: 2019008317
Patent: kit contraceptivo, método contraceptivo para uma paciente do sexo feminino necessitando do mesmo e composição farmacêutica compreendendo drospirenona
Estimated Expiration: ⤷ Try for Free
Canada
Patent: 03721
Patent: COMPOSITION PHARMACEUTIQUE CONTENANT DE LA DROSPIRENONE ET KIT CONTRACEPTIF (PHARMACEUTICAL COMPOSITION COMPRISING DROSPIRENONE AND CONTRACEPTIVE KIT)
Estimated Expiration: ⤷ Try for Free
Patent: 03062
Patent: COMPOSITION PHARMACEUTIQUE CONTENANT DE LA DROSPIRENONE ET KIT CONTRACEPTIF (PHARMACEUTICAL COMPOSITION COMPRISING DROSPIRENONE AND CONTRACEPTIVE KIT)
Estimated Expiration: ⤷ Try for Free
Patent: 61421
Patent: METHOD OF PROVIDING CONTRACEPTION IN A PATIENT
Estimated Expiration: ⤷ Try for Free
Chile
Patent: 12003685
Patent: Kit farmaceutico que comprende una o mas unidades de envasado que comprenden 21 a 28 unidades de dosificacion activas diarias en que cada una comprende por lo menos 2 mg de drosperidona, sin estrogernos; uso del kit y de una composicion farmaceutica que comprende drosperidona para preparar un medicamento util como anticonceptivo.
Estimated Expiration: ⤷ Try for Free
Colombia
Patent: 40328
Patent: Composición farmacéutica que comprende drospirenona y kit anticonceptivo
Estimated Expiration: ⤷ Try for Free
Croatia
Patent: 0200155
Estimated Expiration: ⤷ Try for Free
Patent: 0220332
Estimated Expiration: ⤷ Try for Free
Cyprus
Patent: 22544
Estimated Expiration: ⤷ Try for Free
Patent: 25061
Estimated Expiration: ⤷ Try for Free
Denmark
Patent: 88114
Estimated Expiration: ⤷ Try for Free
Patent: 32448
Estimated Expiration: ⤷ Try for Free
Ecuador
Patent: 12012359
Patent: COMPOSICIÓN FARMACÉUTICA QUE COMPRENDE DROSPIRENONA Y KIT ANTICONCEPTIVO
Estimated Expiration: ⤷ Try for Free
Patent: 15032906
Patent: COMPOSICIÓN FARMACÉUTICA QUE COMPRENDE DROSPIRENONA Y KIT ANTICONCEPTIVO (DIVISIONAL 2 DE SOLICITUD No. SP-12-12359 PCT)
Estimated Expiration: ⤷ Try for Free
Patent: 15032911
Patent: COMPOSICIÓN FARMACÉUTICA QUE COMPRENDE DROSPIRENONA Y KIT ANTICONCEPTIVO (DIVISIONAL 1 DE SOLICITUD No. SP-12-12359 PCT)
Estimated Expiration: ⤷ Try for Free
Eurasian Patent Organization
Patent: 8680
Patent: ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ, СОДЕРЖАЩАЯ ДРОСПИРЕНОН, И НАБОР ДЛЯ ПРЕДУПРЕЖДЕНИЯ ЗАЧАТИЯ (PHARMACEUTICAL COMPOSITION COMPRISING DROSPIRENONE AND CONTRACEPTIVE KIT)
Estimated Expiration: ⤷ Try for Free
Patent: 1291372
Patent: ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ, СОДЕРЖАЩАЯ ДРОСПИРЕНОН, И НАБОР ДЛЯ ПРЕДУПРЕЖДЕНИЯ ЗАЧАТИЯ
Estimated Expiration: ⤷ Try for Free
European Patent Office
Patent: 88114
Patent: COMPOSITION PHARMACEUTIQUE CONTENANT DE LA DROSPIRÉNONE ET KIT CONTRACEPTIF (PHARMACEUTICAL COMPOSITION COMPRISING DROSPIRENONE AND CONTRACEPTIVE KIT)
Estimated Expiration: ⤷ Try for Free
Patent: 32448
Patent: COMPOSITION PHARMACEUTIQUE COMPRENANT DE LA DROSPIRÉNONE ET ENSEMBLE CONTRACEPTIF (PHARMACEUTICAL COMPOSITION COMPRISING DROSPIRENONE AND CONTRACEPTIVE KIT)
Estimated Expiration: ⤷ Try for Free
Patent: 56186
Patent: COMPOSITION PHARMACEUTIQUE COMPRENANT DE LA DROSPIRÉNONE ET ENSEMBLE CONTRACEPTIF (PHARMACEUTICAL COMPOSITION COMPRISING DROSPIRENONE AND CONTRACEPTIVE KIT)
Estimated Expiration: ⤷ Try for Free
France
Patent: C1020
Estimated Expiration: ⤷ Try for Free
Patent: C1031
Estimated Expiration: ⤷ Try for Free
Guatemala
Patent: 1200336
Patent: COMPOSICIÒN FARMACÈUTICA QUE COMPRENDE DROSPIRENONA Y KIT ANTICONCEPTIVO
Estimated Expiration: ⤷ Try for Free
Patent: 1200336A
Patent: COMPOSICIÓN FARMACÉUTICA QUE COMPRENDE DROSPIRENONA Y KIT ANTICONCEPTIVO (SOLICITUD DIVISIONAL NO. 1)
Estimated Expiration: ⤷ Try for Free
Patent: 1200336B
Patent: COMPOSICIÓN FARMACÉUTICA QUE COMPRENDE DROSPIRENONA Y KIT ANTICONCEPTIVO (SOLICITUD DIVISIONAL NO. 2)
Estimated Expiration: ⤷ Try for Free
Hungary
Patent: 47689
Estimated Expiration: ⤷ Try for Free
Patent: 58176
Estimated Expiration: ⤷ Try for Free
Patent: 000016
Estimated Expiration: ⤷ Try for Free
Patent: 200018
Estimated Expiration: ⤷ Try for Free
Japan
Patent: 10159
Estimated Expiration: ⤷ Try for Free
Patent: 13529665
Estimated Expiration: ⤷ Try for Free
Lithuania
Patent: 2021523
Estimated Expiration: ⤷ Try for Free
Patent: 2022513
Estimated Expiration: ⤷ Try for Free
Patent: 88114
Estimated Expiration: ⤷ Try for Free
Patent: 32448
Estimated Expiration: ⤷ Try for Free
Mexico
Patent: 9952
Patent: COMPOSICION FARMACEUTICA QUE COMPRENDE DROSPIRENONA Y KIT ANTICONCEPTIVO. (PHARMACEUTICAL COMPOSITION COMPRISING DROSPIRENONE AND CONTRACEPTIVE KIT.)
Estimated Expiration: ⤷ Try for Free
Patent: 4971
Patent: COMPOSICION FARMACEUTICA QUE COMPRENDE DROSPIRENONA Y KIT ANTICONCEPTIVO. (PHARMACEUTICAL COMPOSITION COMPRISING DROSPIRENONE AND CONTRACEPTIVE KIT.)
Estimated Expiration: ⤷ Try for Free
Patent: 12014629
Patent: COMPOSICION FARMACEUTICA QUE COMPRENDE DROSPIRENONA Y KIT ANTICONCEPTIVO. (PHARMACEUTICAL COMPOSITION COMPRISING DROSPIRENONE AND CONTRACEPTIVE KIT.)
Estimated Expiration: ⤷ Try for Free
Patent: 19004393
Patent: COMPOSICION FARMACEUTICA QUE COMPRENDE DROSPIRENONA Y KIT ANTICONCEPTIVO. (PHARMACEUTICAL COMPOSITION COMPRISING DROSPIRENONE AND CONTRACEPTIVE KIT.)
Estimated Expiration: ⤷ Try for Free
New Zealand
Patent: 5176
Patent: Pharmaceutical composition comprising drospirenone and contraceptive kit
Estimated Expiration: ⤷ Try for Free
Norway
Patent: 20015
Estimated Expiration: ⤷ Try for Free
Patent: 22030
Estimated Expiration: ⤷ Try for Free
Peru
Patent: 130780
Patent: COMPOSION FARMACEUTICA QUE COMPRENDE DROSPIRENONA Y KIT ANTICONCEPTIVO
Estimated Expiration: ⤷ Try for Free
Patent: 161410
Patent: COMPOSICION FARMACEUTICA QUE COMPRENDE DROSPIRENONA Y KIT ANTICONCEPTIVO
Estimated Expiration: ⤷ Try for Free
Poland
Patent: 88114
Estimated Expiration: ⤷ Try for Free
Patent: 32448
Estimated Expiration: ⤷ Try for Free
Portugal
Patent: 88114
Estimated Expiration: ⤷ Try for Free
Patent: 32448
Estimated Expiration: ⤷ Try for Free
San Marino
Patent: 02000063
Estimated Expiration: ⤷ Try for Free
Patent: 02200129
Estimated Expiration: ⤷ Try for Free
Serbia
Patent: 826
Patent: FARMACEUTSKA KOMPOZICIJA KOJA OBUHVATA DROSPIRENON I KONTRACEPTIVNI KOMPLET (PHARMACEUTICAL COMPOSITION COMPRISING DROSPIRENONE AND CONTRACEPTIVE KIT)
Estimated Expiration: ⤷ Try for Free
Patent: 027
Patent: FARMACEUTSKA KOMPOZICIJA KOJA OBUHVATA DROSPIRENON ZA UPOTREBU KAO KONTRACEPTIV (PHARMACEUTICAL COMPOSITION COMPRISING DROSPIRENONE FOR USE AS A CONTRACEPTIVE)
Estimated Expiration: ⤷ Try for Free
Slovenia
Patent: 88114
Estimated Expiration: ⤷ Try for Free
Patent: 32448
Estimated Expiration: ⤷ Try for Free
South Africa
Patent: 1209743
Patent: PHARMACEUTICAL COMPOSITION COMPRISING DROSPIRENONE AND CONTRACEPTIVE KIT
Estimated Expiration: ⤷ Try for Free
South Korea
Patent: 2164693
Estimated Expiration: ⤷ Try for Free
Patent: 2210982
Estimated Expiration: ⤷ Try for Free
Patent: 2539030
Estimated Expiration: ⤷ Try for Free
Patent: 130048227
Patent: PHARMACEUTICAL COMPOSITION COMPRISING DROSPIRENONE AND CONTRACEPTIVE KIT
Estimated Expiration: ⤷ Try for Free
Patent: 170085604
Patent: 드로스피레논을 포함하는 약학적 조성물 및 피임용 키트 (Pharmaceutical composition comprising drospirenone and contraceptive kit)
Estimated Expiration: ⤷ Try for Free
Patent: 190073598
Patent: 드로스피레논을 포함하는 약학적 조성물 및 피임용 키트 (Pharmaceutical composition comprising drospirenone and contraceptive kit)
Estimated Expiration: ⤷ Try for Free
Patent: 210013663
Patent: 드로스피레논을 포함하는 약학적 조성물 및 피임용 키트 (Pharmaceutical composition comprising drospirenone and contraceptive kit)
Estimated Expiration: ⤷ Try for Free
Spain
Patent: 77886
Estimated Expiration: ⤷ Try for Free
Patent: 08657
Estimated Expiration: ⤷ Try for Free
Generics may enter earlier, or later, based on new patent filings, patent extensions, patent invalidation, early generic licensing, generic entry preferences, and other factors.
See the table below for additional patents covering SLYND around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Norway | 2020015 | ⤷ Try for Free | |
France | 20C1020 | ⤷ Try for Free | |
Lithuania | PA2022513 | ⤷ Try for Free | |
South Korea | 20170085604 | 드로스피레논을 포함하는 약학적 조성물 및 피임용 키트 (Pharmaceutical composition comprising drospirenone and contraceptive kit) | ⤷ Try for Free |
Ecuador | SP12012359 | COMPOSICIÓN FARMACÉUTICA QUE COMPRENDE DROSPIRENONA Y KIT ANTICONCEPTIVO | ⤷ Try for Free |
Lithuania | PA2021523 | ⤷ Try for Free | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for SLYND
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
2588114 | 19/2020 | Austria | ⤷ Try for Free | PRODUCT NAME: DROSPIRENON; NAT. REGISTRATION NO/DATE: 139227 20191206; FIRST REGISTRATION: DK 31332 (MITTEILUNG) 20191022 |
1214076 | C01214076/01 | Switzerland | ⤷ Try for Free | PRODUCT NAME: DROSPIRENONE + ETHINYLESTRADIOL; REGISTRATION NUMBER/DATE: SWISSMEDIC 57946 13.06.2008 |
0398460 | SPC/GB04/032 | United Kingdom | ⤷ Try for Free | PRODUCT NAME: ESTRADIOL, OPTIONALLY IN THE FORM OF A HYDRATE, TOGETHER WITH DROSPIRENONE; REGISTERED: NL RVG 27505 20021211; UK PL 00053/0341 20040310 |
3632448 | 2022C/529 | Belgium | ⤷ Try for Free | PRODUCT NAME: DROSPIRENON; AUTHORISATION NUMBER AND DATE: BE548284 20191107 |
3632448 | LUC00266 | Luxembourg | ⤷ Try for Free | PRODUCT NAME: DROSPIRENONE; AUTHORISATION NUMBER AND DATE: 61678, 20210401 |
2588114 | 2020C/518 | Belgium | ⤷ Try for Free | PRODUCT NAME: DROSPIRENON; AUTHORISATION NUMBER AND DATE: BE548284 20191107 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Market Dynamics and Financial Trajectory for SLYND
More… ↓